Caroline Jefferies, PhD
Cedars-Sinai Medical Center
Beverly Hills, CA, United States
Disclosure(s): Amgen: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Eli Lilly: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
Betsy Barnes, PhD
Northwell Health
Manhasset, New York, United States
Disclosure information not submitted.
This session will define and discuss inflammaging - the chronic, low-grade inflammation that accompanies aging, and its role in the development and progression of rheumatic diseases. This session aims to focus on the mechanisms driving age-related immune dysfunction and their role in progression of rheumatic diseases.
Speaker: Maxim Artyomov, PhD – Washington University School of Medicine
Speaker: Lev Silberstein, MD, PhD – Fred Hutch, Seattle
Speaker: Inez Rogatsky, PhD – Hospital for Special Surgery